One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
Effectiveness of Rhythm Control of Atrial Fibrillation in Moderate-to-Severe or Severe Secondary Tricuspid Regurgitation
doi : 10.1016/j.jcmg.2026.03.006
Volume 19, Issue 6, June 2026, Pages 673-683
The Dual Menaces of Atrial Fibrillation and Tricuspid Regurgitation in Heart Failure: Fighting a War on 2 Fronts
doi : 10.1016/j.jcmg.2026.04.003
Volume 19, Issue 6, June 2026, Pages 684-687
Serial Myocardial Fibrosis Assessments Predict Outcomes in Patients With Hypertrophic Cardiomyopathy
doi : 10.1016/j.jcmg.2026.01.008
Volume 19, Issue 6, June 2026, Pages 688-701
Myocardial Fibrosis by Late Gadolinium Enhancement Among Patients With Hypertrophic Cardiomyopathy: Worth a Repeat Look?
doi : 10.1016/j.jcmg.2026.03.009
Volume 19, Issue 6, June 2026, Pages 702-705
Guiding Preventive Care Strategies for Patients With Atherosclerotic Plaque on Coronary CTA: Primary Outcomes of the DECIDE Registry
doi : 10.1016/j.jcmg.2026.01.014
Volume 19, Issue 6, June 2026, Pages 706-716
When Plaque Helps Us DECIDE
doi : 10.1016/j.jcmg.2026.02.017
Volume 19, Issue 6, June 2026, Pages 717-719
Epicardial Adipose Tissue, Coronary Plaque Progression, and Major Adverse Cardiovascular Events: A Multicenter Study
doi : 10.1016/j.jcmg.2026.02.003
Volume 19, Issue 6, June 2026, Pages 720-731
Assessing Cardiometabolic Risk Through Epicardial Adipose Tissue Imaging
doi : 10.1016/j.jcmg.2026.02.016
Volume 19, Issue 6, June 2026, Pages 732-734
A Novel Breast Arterial Calcification Age-Based Percentile Nomogram for the Incremental Prediction of Incidental Cardiovascular Events
doi : 10.1016/j.jcmg.2026.03.008
Volume 19, Issue 6, June 2026, Pages 735-748
Wishing for A Sex-Specific, Imaging-Based, Widely Available, Cardiovascular Risk Enhancer?: Your BAC Is Already Here
doi : 10.1016/j.jcmg.2026.04.004
Volume 19, Issue 6, June 2026, Pages 749-751
Systematic Review of International Population Studies With Cardiac Magnetic Resonance and Genomics Research Data (“Imagenomics”)
doi : 10.1016/j.jcmg.2026.01.007
Volume 19, Issue 6, June 2026, Pages 752-767
Imaging-Genomics Databases: Enabling and Accelerating Precision Medicine
doi : 10.1016/j.jcmg.2026.02.015
Volume 19, Issue 6, June 2026, Pages 768-770
Mitral Annular Disjunction in Pediatric Loeys-Dietz Syndrome: A Step Toward Deep Phenotyping
doi : 10.1016/j.jcmg.2025.10.023
Volume 19, Issue 6, June 2026, Pages 771-773
Modeling Benefit of Aspirin According to Lp(a) and Coronary Artery Calcium: MESA
doi : 10.1016/j.jcmg.2025.12.008
Volume 19, Issue 6, June 2026, Pages 774-776
Impact of Residual Vegetations After Treatment of Left-Sided Infective Endocarditis: A Substudy of the POET Trial
doi : 10.1016/j.jcmg.2026.01.002
Volume 19, Issue 6, June 2026, Pages 777-778
AI-Derived Ischemia Score From Coronary CT Angiography Predicts Myocardial Infarctions: Insights From the SCOT-HEART Trial
doi : 10.1016/j.jcmg.2026.01.004
Volume 19, Issue 6, June 2026, Pages 779-781
Repeated Visualization of Coronary Calcium and Long-term Outcomes: A CAUGHT-CAD Subanalysis
doi : 10.1016/j.jcmg.2026.01.012
Volume 19, Issue 6, June 2026, Pages 782-784
Beyond Global Viability: Patient-Specific Identification of Jeopardized Myocardium to Guide Revascularization
doi : 10.1016/j.jcmg.2026.01.015
Volume 19, Issue 6, June 2026, Page 785
REPLY: Beyond Global Viability: Patient-Specific Identification of Jeopardized Myocardium to Guide Revascularization
doi : 10.1016/j.jcmg.2026.02.008
Volume 19, Issue 6, June 2026, Page 786
Heterogeneity and Beyond: Unaddressed Pitfalls in the Meta-Analysis of Advanced CTA for MACE Prediction
doi : 10.1016/j.jcmg.2025.12.014
Volume 19, Issue 6, June 2026, Page 787
REPLY: Heterogeneity and Beyond: Unaddressed Pitfalls in the Meta-Analysis of Advanced CTA for MACE Prediction
doi : 10.1016/j.jcmg.2026.02.009
Volume 19, Issue 6, June 2026, Page 788
From Curves to Clinic: Making CTA-Guided Statins Actionable
doi : 10.1016/j.jcmg.2025.11.012
Volume 19, Issue 6, June 2026, Page 789
REPLY: From Curves to Clinic: Making CTA-Guided Statins Actionable
doi : 10.1016/j.jcmg.2026.03.010
Volume 19, Issue 6, June 2026, Page 790
Current Status and Future Research Priorities for CMR Cardiomyopathy Assessment: Exciting Times for Protons and Patients
doi : 10.1016/j.jcmg.2026.05.001
Volume 19, Issue 6, June 2026, Pages 791-794
